乳房再造结局报告质量评估:五年范围综述
该范围综述筛查了2015至2021年《整形与重建外科》和《整形外科年鉴》中833篇乳房再造文献,纳入192篇原创研究,使用改编自普通外科的结局报告标准进行评估,发现研究设计、并发症纳入和定义方面存在显著报告缺口,且2015至2021年较2000至2014年改善甚微,支持需要建立乳房再造结局报告标准。
要点
- 192篇纳入研究中仅27.42%定义了至少一半的并发症,仅24.19%使用了严重程度分级。
- 感染是最常报告的并发症(62.71%),但使用了18种不同的定义。
- 平均仅满足10项报告标准中的3.3项,2015至2021年较2000至2014年改善甚微。
核心结论
- 本研究发现在研究设计、纳入的并发症和使用的定义方面存在显著结局报告缺口。
- 2015至2021年结局报告较2000至2014年期间改善甚微。
- 本研究支持需要乳房再造结局报告标准以提高研究的普遍性和质量。
研究设计与样本
- 范围综述,筛查2015至2021年《整形与重建外科》和《整形外科年鉴》中所有与乳房再造相关的原创文章。
- 共审查833篇乳房再造文章,192篇符合纳入标准。
- 使用改编自普通外科文献的现有乳房再造结局报告标准对纳入文章进行评估。
主要发现
- 约一半文章(n=87 [45.38%])涉及自体乳房再造,127篇(66%)涉及假体乳房再造,31篇(16.15%)同时包含两种手术。
- 不足五分之一的研究(n=53 [27.42%])定义了至少一半的并发症。
- 不足三分之一的研究纳入了至少一半的建议手术特异性并发症(n=53 [27.42%])、使用了严重程度分级(n=46 [24.19%])或在分析中考虑了危险因素(n=64 [33.33%])。
- 感染是最常报告的并发症(n=120 [62.71%]),使用了18种不同的定义。
- 结局报告标准评估显示,平均满足10项可能标准中的3.3项。
关键数值与推荐
- 并发症定义:53/192(27.42%)定义了至少一半的并发症。
- 手术特异性并发症:53/192(27.42%)纳入了至少一半的建议手术特异性并发症。
- 严重程度分级:46/192(24.19%)使用了严重程度分级。
- 危险因素分析:64/192(33.33%)在分析中考虑了危险因素。
- 感染报告:120/192(62.71%)报告了感染,使用18种不同定义。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Outcomes reporting is essential to advancing health care quality in plastic surgery and aligns closely with patient satisfaction. At present, there is no widely used set of standards for breast reconstruction reporting in the literature. This study aimed to define how breast reconstruction outcomes are characterized in the literature and identify opportunities to improve consistency across studies. METHODS: All articles published between 2015 and 2021 in Plastic and Reconstructive Surgery and Annals of Plastic Surgery were screened for original articles that pertained to breast reconstruction. Included articles were evaluated using existing outcomes reporting criteria for breast reconstruction that were adapted from general surgery literature. RESULTS: Of 833 breast reconstruction articles reviewed, 192 met inclusion criteria. Approximately one-half of the articles ( n = 87 [45.38%]) pertained to autologous breast reconstruction, 127 (66%) pertained to prosthetic breast reconstruction, and 31 (16.15%) included both procedures. Less than one-fifth of studies ( n = 53 [27.42%]) defined at least half of the complications in their study. Less than one-third included at least half of the suggested procedure-specific complications ( n = 53 [27.42%]), used severity grades ( n = 46 [24.19%]), or considered risk factors in analyses ( n = 64 [33.33%]). Infection was the most reported complication ( n = 120 [62.71%]), and 18 distinct definitions were used. Outcomes reporting criteria assessment revealed the average number of criteria met was 3.3 of a possible 10. CONCLUSIONS: This study found significant gaps in outcomes reporting with regard to study design, complications included, and definitions used. There was little improvement in outcomes reporting from 2015 to 2021 compared with the period from 2000 to 2014. This study supports the need for outcomes reporting standards in breast reconstruction to improve study generalizability and quality.
引用
- Biswas S, Mullikin AM, Zeng SL, et al. Assessing the Quality of Breast Reconstruction Outcomes Reporting: A 5-Year Scoping Review. Plast Reconstr Surg. 2025. PMID: 40178870. doi:10.1097/PRS.0000000000012133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。